KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Change in Accured Expenses (2016 - 2025)

Evolent Health has reported Change in Accured Expenses over the past 11 years, most recently at $7.4 million for Q4 2025.

  • Quarterly results put Change in Accured Expenses at $7.4 million for Q4 2025, up 118.24% from a year ago — trailing twelve months through Dec 2025 was $3.0 million (up 113.04% YoY), and the annual figure for FY2025 was $3.0 million, up 113.04%.
  • Change in Accured Expenses for Q4 2025 was $7.4 million at Evolent Health, up from $1.5 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for EVH hit a ceiling of $26.8 million in Q2 2024 and a floor of -$40.3 million in Q4 2024.
  • Median Change in Accured Expenses over the past 5 years was $2.6 million (2021), compared with a mean of -$1.1 million.
  • Biggest five-year swings in Change in Accured Expenses: crashed 1330.38% in 2021 and later soared 606.76% in 2023.
  • Evolent Health's Change in Accured Expenses stood at $17.4 million in 2021, then plummeted by 105.09% to -$888000.0 in 2022, then crashed by 337.39% to -$3.9 million in 2023, then tumbled by 938.18% to -$40.3 million in 2024, then surged by 118.24% to $7.4 million in 2025.
  • The last three reported values for Change in Accured Expenses were $7.4 million (Q4 2025), $1.5 million (Q3 2025), and $13.0 million (Q2 2025) per Business Quant data.